35Indexed trials
canonical disease area
Bipolar Disorder
Intelligence
Bipolar Disorder intelligence: 35 indexed trials, 8 recruiting studies, 29 sponsors across 33 countries.
8Recruiting
29Sponsors
33Countries
Leading sponsors
University Hospitals Cleveland Medical Center31 recruiting
Sumitomo Pharma America, Inc.20 recruiting
Otsuka Pharmaceutical Development & Commercialization, Inc.20 recruiting
University of California, Los Angeles21 recruiting
Massachusetts General Hospital20 recruiting
Fondazione Policlinico Universitario Agostino Gemelli IRCCS11 recruiting
Bjorn H. Ebdrup11 recruiting
Assistance Publique Hopitaux De Marseille10 recruiting
Mclean Hospital11 recruiting
Biohaven Therapeutics Ltd.10 recruiting
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital10 recruiting
Mary Phillips, MD MD (Cantab)10 recruiting
Geographic activity
United States23trials
France7trials
Russia4trials
India3trials
Czechia3trials
Japan2trials
Bulgaria2trials
Denmark2trials
Canada2trials
Chile2trials
Brazil2trials
Italy2trials
Leading interventions
Lurasidone2trials
Psychoeducation2trials
Antipsychotic1trials
Aripiprazole1trials
Asenapine1trials
BHV-70001trials
Continuous Theta Burst Stimulation (cTBS)1trials
CAG Bipola and mood monitoring only1trials
Curcumin1trials
Eye Movement Desensitization and Reprocessing (EMDR) Therapy1trials
Eye tracking1trials
Antipsychotic and Antidepressant1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.